This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
reit: Archive
Is Extra Space Storage Stock a Good Bet Ahead of Q2 Earnings?
by Zacks Equity Research
EXR heads into Q2 earnings with revenue growth expected, but intense competition could pressure pricing and temper results.
EXRNegative Net Change BXPNegative Net Change CUZNegative Net Change
finance reit
AGNC Investment Q2 Earnings Call Highlights Agency MBS Outlook
by Zacks Equity Research
AGNC sees improving Agency MBS supply-demand trends, stronger book value and higher-coupon opportunities despite a volatile rate backdrop.
AGNCNegative Net Change
earnings reit
Pick These 5 Low Price-to-Sales Stocks to Help Boost Portfolio Returns
by Rajani Lohia
CAL, PEB, BCC, APLE and PARR combine low price-to-sales ratios with strong fundamentals, disciplined execution and long-term growth drivers.
PEBNegative Net Change BCCNegative Net Change CALNegative Net Change APLENegative Net Change PARRPositive Net Change
construction consumer-discretionary finance oil-energy reit
American Tower to Post Q2 Earnings: Is AMT a Portfolio Must-Have?
by Zacks Equity Research
AMT heads into Q2 2026 results with revenue and AFFO growth expected, as 5G, mobile data demand and CoreSite momentum offset the DISH-related churn.
AMTPositive Net Change CUZNegative Net Change DLRNegative Net Change
finance reit
BXP to Post Q2 Earnings: Is the Stock a Portfolio Must-Have?
by Zacks Equity Research
BXP to report Q2 results on July 28, with AI-driven leasing, strong demand for premium offices and signed deals in focus as revenues are expected to edge higher.
BXPNegative Net Change CUZNegative Net Change DLRNegative Net Change
finance reit
Welltower Gears Up to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
WELL heads into Q2 earnings with revenues and normalized FFO growth expected, backed by senior housing demand and muted supply.
WELLPositive Net Change BXPNegative Net Change CUZNegative Net Change
finance reit
Healthpeak & Brookfield Form Outpatient Medical Joint Venture
by Zacks Equity Research
DOC's $2.1 billion outpatient medical portfolio joint venture with BAM provides long-term capital while preserving control and future growth potential.
BAMNegative Net Change DOCNo Net Change WELLPositive Net Change PSTLPositive Net Change
finance reit
UDR to Post Q2 Earnings: Is the Stock a Portfolio Must-Have?
by Zacks Equity Research
UDR heads into Q2 results with steady revenue growth expected, as improving apartment demand, strong occupancy and coastal markets support operations.
UDRNegative Net Change CUZNegative Net Change SLGNegative Net Change
finance reit
Do Options Traders Know Something About AH Realty Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to AHRT stock based on the movements in the options market lately.
AHRTNegative Net Change
finance reit
Is WPC Stock Worth Retaining in Your Portfolio for the Long Run?
by Zacks Equity Research
W.P. Carey benefits from stable triple-net leases, strong occupancy and disciplined investments, but debt, competition and tenant risks remain challenges.
WPCPositive Net Change PEBNegative Net Change CTOPositive Net Change
finance reit